BHC
NYSE · Pharmaceuticals
Bausch Health Cos Inc
$8.15
+0.19 (+2.39%)
Performance
1D
-0.37%
1W
+1.62%
1M
+34.93%
3M
+28.35%
6M
+51.77%
1Y
+22.56%
YTD
+13.04%
Open$7.86
Previous Close$7.96
Day High$8.20
Day Low$7.86
52W High$12.65
52W Low$6.10
Volume—
Avg Volume1.03M
Market Cap4.37B
P/E Ratio—
EPS$-2.96
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$6.40
Above
SMA 200
$5.73
Above
RSI (14)
69.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
8 analysts
Price Target
+1,173.4% upside
Current
$8.15
$8.15
Target
$103.78
$103.78
$65.08
$103.78 avg
$115.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.67B | 13.57B | 415.01M |
| Net Income | 224.39M | 186.80M | 120.28M |
| Profit Margin | 1.5% | 1.5% | 29.0% |
| EBITDA | 4.25B | 3.74B | 156.90M |
| Free Cash Flow | — | — | 115.51M |
| Rev Growth | +8.1% | +8.1% | +10.0% |
| Debt/Equity | 44.72 | 44.72 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |